Herbalife announced that global sports icon Cristiano Ronaldo has acquired a 10% equity interest in HBL Pro2col Software, LLC, an indirect wholly owned subsidiary that holds the company’s Pro2col technology. Ronaldo invested $7.5 million in the platform and committed to provide services and sponsorship rights to Pro2col Software.